Analyst Ratings for Keryx Biopharmaceuticals (KERX)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 3.5 / 10
Percentile Rank: 37%
Rating Score: 3.5 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/12/2018 | Raymond James | Reni Benjamin | Downgrade | Market Perform (Outperform) |
N/A (N/A) |
3.03 (3.36) |
10.89% | Details |
| 6/28/2018 | Maxim Group | N/A | Downgrade | Hold (Buy) |
N/A (N/A) |
4.48 (3.36) |
-25% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


